Atrial fibrillation with RVR: Difference between revisions

No edit summary
Line 1: Line 1:
==Unstable (Cardioversion)==
== Unstable (Cardioversion) ==


*Indications
*Indications
Line 7: Line 7:
**AMS
**AMS
*Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs)
*Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs)
#Sedate:  Versed / Ativan / Fentanyl
#Initial 100J monophasic or 50-70j biphasic synchronized cardioversion


==Stable but sympomatic (Rate Control)==
#Sedate: Versed / Ativan / Fentanyl
#Initial 100J monophasic or 50-70j biphasic synchronized cardioversion
 
== Stable but sympomatic (Rate Control) ==


*Goal < 110bpm1
*Goal < 110bpm1
Line 17: Line 18:
*No evidence that pharmacological rate control has any adverse influence on LV dysfunction
*No evidence that pharmacological rate control has any adverse influence on LV dysfunction


Calcium-Channel Blockers
'''Calcium-Channel Blockers'''
*Preferred in pts with chronic lung disease or low EF  
 
*Preferred in pts with chronic lung disease or low EF
*Contraindications
*Contraindications
**Decompensated heart failure
**Decompensated heart failure
**Preexcitation
**Preexcitation
**Significant hypotension  
**Significant hypotension
*Diltiazem
 
**Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
'''Diltiazem<br/>'''
***If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)  
 
***If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr  
*Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
**Takes 2-5 minutes to work, last 1-4 hours
**If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)
**94% responive
**If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr
**If effective, can start PO dilt at 30mg QID
*Takes 2-5 minutes to work, last 1-4 hours
*94% responive
*If effective, can start PO dilt at 30mg QID
 
'''Beta-Blockers'''


Beta-Blockers
*Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
*Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
*Contraindicated in COPD, low EF CHF  
*Contraindicated in COPD, low EF CHF
*Metoprolol
*Metoprolol
**2.5-5mg IVP over 2min q5 min up to 3 doses
**2.5-5mg IVP over 2min q5 min up to 3 doses
Line 42: Line 47:
***If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
***If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
***If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
***If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
*PO load with MTP 25-50mg following successful rate control with IV  
*PO load with MTP 25-50mg following successful rate control with IV
 
'''Digoxin'''


Digoxin
*Consider as initial therapy for pts with LV dysfunction who:
*Consider as initial therapy for pts with LV dysfunction who:
**Do not achieve rate control targets on beta blockers alone
**Do not achieve rate control targets on beta blockers alone
**Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
**Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
**Would have digoxin added anyway to improve CHF symptoms independent of AF  
**Would have digoxin added anyway to improve CHF symptoms independent of AF
*Consider as initial therapy in pts with severe hypotension
*Consider as initial therapy in pts with severe hypotension
*Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
*Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
*May take up to 6-8 hours to work
*May take up to 6-8 hours to work
Line 56: Line 62:
**Adjust dose in presence of renal failure, amiodarone, etc
**Adjust dose in presence of renal failure, amiodarone, etc


Amiodarone  
'''Amiodarone'''
*Consider for use in pts with decompensated heart failure or those with accessory pathways  
 
*Consider for use in pts with decompensated heart failure or those with accessory pathways
*2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
*2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
*Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses
*Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses


==Stable and asymptomatic==
== Stable and asymptomatic ==
* If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds
 
*If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds
 
== Evidence of preexcitation ==


==Evidence of preexcitation==
*Initial therapy is aimed at reversion to sinus rhythm
*Initial therapy is aimed at reversion to sinus rhythm
**Unstable -> urgent cardioversion
**Unstable -> urgent cardioversion
Line 72: Line 81:
*****20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
*****20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
**Stable -> try to avoid cardioversion without adequate anticoagulation
**Stable -> try to avoid cardioversion without adequate anticoagulation
**Avoid AV nodal agents  
**Avoid AV nodal agents


==See Also==
== See Also ==


Atrial Fibrillation (Gen)
Atrial Fibrillation (Gen)


==Source ==
== Source ==


1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture
1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture


1RACE II study
1RACE II study


[[Category:Cards]]
<br/>[[Category:Cards]]

Revision as of 18:30, 9 March 2011

Unstable (Cardioversion)

  • Indications
    • Ischemic CP
    • SBP < 90
    • Acute pulmonary edema
    • AMS
  • Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs)
  1. Sedate: Versed / Ativan / Fentanyl
  2. Initial 100J monophasic or 50-70j biphasic synchronized cardioversion

Stable but sympomatic (Rate Control)

  • Goal < 110bpm1
  • Be careful that you are not slowing down a normal physiologic response!
    • RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal
  • No evidence that pharmacological rate control has any adverse influence on LV dysfunction

Calcium-Channel Blockers

  • Preferred in pts with chronic lung disease or low EF
  • Contraindications
    • Decompensated heart failure
    • Preexcitation
    • Significant hypotension

Diltiazem

  • Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
    • If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)
    • If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr
  • Takes 2-5 minutes to work, last 1-4 hours
  • 94% responive
  • If effective, can start PO dilt at 30mg QID

Beta-Blockers

  • Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
  • Contraindicated in COPD, low EF CHF
  • Metoprolol
    • 2.5-5mg IVP over 2min q5 min up to 3 doses
  • Esmolol
    • Use if unsure whether pt will tolerate a BB (duration of action is only 10-20min)
    • Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
      • If, after 4 minutes response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
      • If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
      • If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
  • PO load with MTP 25-50mg following successful rate control with IV

Digoxin

  • Consider as initial therapy for pts with LV dysfunction who:
    • Do not achieve rate control targets on beta blockers alone
    • Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
    • Would have digoxin added anyway to improve CHF symptoms independent of AF
  • Consider as initial therapy in pts with severe hypotension
  • Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
  • May take up to 6-8 hours to work
  • Dosing
    • 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
    • Adjust dose in presence of renal failure, amiodarone, etc

Amiodarone

  • Consider for use in pts with decompensated heart failure or those with accessory pathways
  • 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
  • Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses

Stable and asymptomatic

  • If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds

Evidence of preexcitation

  • Initial therapy is aimed at reversion to sinus rhythm
    • Unstable -> urgent cardioversion
      • DC cardioversion
      • Pharmacologic cardioversion
        • Procainamide
          • 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
    • Stable -> try to avoid cardioversion without adequate anticoagulation
    • Avoid AV nodal agents

See Also

Atrial Fibrillation (Gen)

Source

1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture

1RACE II study